TrialBlood cancer journal2015

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation.

V Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.